After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
HSD11B2 catalyzes the conversion of cortisol to the inactive metabolite cortisone. The protein modulates intracellular glucocorticoid levels, thus protecting the nonselective mineralocorticoid receptor from occupation by glucocorticoids. Defects in HSD11B2 are the cause of apparent mineralocorticoid excess (AME). AME is a potentially fatal disease characterized by severe juvenile low-renin hypertension, sodium retention, hypokalemia and low levels of aldosterone. It often leads to nephrocalcinosis.
![Western Blot HSD11B2 Antibody (921215) [Unconjugated]](http://images.novusbio.com/fullsize/antibody/11_betaHSD2_MAB8630_Western_Blot_16837.jpg)
![Immunohistochemistry HSD11B2 Antibody (921215) [Unconjugated]](http://images.novusbio.com/fullsize/antibody/11_betaHSD2_MAB8630_Immunohistochemistry_16831.jpg)
![Simple Western HSD11B2 Antibody (921215) [Unconjugated]](http://images.novusbio.com/fullsize/mab8630_human-11-beta-hsd2-mab-clone-921215-simple-western-639167152776180627.jpg)
